Check out a recent blog post by Dick Clarke, President of National Baromedical Services, Inc, about the American Diabetes Association’s (ADA) “Standards of Medical Care in Diabetes 2020,” assessment of Hyperbaric oxygen therapy for DFUs.
The ADA’s assessment of HBOT was largely based on the discredited Fedorko study, a topic which I blogged about a long time ago.
The endpoint for the Fedorko study was a photographic assessment of whether a foot should be amputated, not whether it actually WAS amputated or ultimately healed. The photo assessment was wrong the vast majority of the time (most patients allocated to “amputation” actually healed), but the real outcomes data were never published.
Here’s a video by a patient who was allocated to the “amputated category,” but who wanted to show that she completely healed with HBOT and was ambulatory.
You can’t make this stuff up. Well, actually, if you are a socialized healthcare system like Canada and don’t want to pay for HBOT, apparently you CAN just make stuff up. That’s food for thought.